2014 Healthcare Networking Safety 
Legacy MEDSearch
JUNE 27, 2022
Centerline), a private medical technology company, announced the closing of a $33 million Series B equity financing led by Cleveland Clinic with participation by GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures and G2 Group Ventures. Founded in 2014, Centerline Biomedical is headquartered in Cleveland, Ohio.
European Pharmaceutical Review
AUGUST 23, 2022
FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. They are also smartphone-readable, generating a digitalised security key augmented by a deep neural network. This allows for a cyber? About the author. Available from: [link].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 9, 2022
The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. The keynote address of the event entire came from Stella Kyriakides, commissioner for health and food safety at the European Commission. Her opener?
European Pharmaceutical Review
JUNE 27, 2023
Hervé Affagard (HA): Developing microbiome therapeutics as well as every other new therapeutic modality comes with several challenges that need to be addressed carefully to ensure patient safety and maximise the potential benefits of these treatments. For the past 15 years, Hervé has been an intra/entrepreneur in the healthcare industry.
pharmaphorum
OCTOBER 26, 2022
There are many challenges in the development of therapies for rare diseases due to several unique factors, including small target patient populations, lack of long-term safety and efficacy data or natural history data, and often complex administration, dosing, and patient monitoring requirements,” Chiesi says. Chiesi’s philosophy in action.
Clarivate
MAY 31, 2024
Drug repurposing, or drug repositioning, aims to identify existing drugs—either those already on the market or those that have passed human safety assessments—that can be used to treat conditions other than those they were originally developed for. The use of RWD in the drug discovery process spans many stages.
Clarivate
MAY 13, 2024
Insurance exchanges underwent their largest single-year enrollment growth since their inception in 2014, pushing exchange enrollment to yet another all-time high. This post was authored by: Bill Melville, Lead Healthcare Research and Data Analyst; Paula Wade, Lead Healthcare Research and Data Analyst; and Valerie E.
Expert insights. Personalized for you.
52 
Let's personalize your content